Reduced Non-Relapse Mortality (NRM) and survivable acute Graft versus Host Disease (GVHD) in the current era of myeloablative ex vivo T-Cell Cepleted (TCD) transplantation.
Citation: Unpublished 2017/10/03Department: Medicine/General Internal MedicineForm of publication: Poster PresentationYear: 2017Conference information: MedStar Washington Hospital Center: MedStar Health Research Symposium, North Bethesda, MD., Fiscal year: FY2018Local accession number: A2017_255Date added to catalog: 2018-08-01Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Poster Presentation | MedStar Authors Catalog | Poster | Available |